Tandem Diabetes Care earnings beat by $0.08, revenue topped estimates
ArchivedVerified|4 articles|2 sources|1 blocks
Detected: Updated: Analyzed:
Reported Facts
Observable data points shared across all narratives
- •Tandem Diabetes Care reported earnings per share that exceeded analyst consensus estimates by $0.08.
- •Tandem Diabetes Care reported quarterly revenue that came in above analyst expectations.
- •EuroDry reported earnings that beat analyst expectations by $0.39 and revenue that topped estimates.
- •Rimini Street reported GAAP EPS of $0.39, beating analyst expectations by $0.35, and revenue of $109.8 million, beating by $4.33 million.
- •Chemours reported Non-GAAP EPS of $0.05, beating expectations by $0.03, with revenue of $1.33 billion roughly in line with estimates.
What Could Happen If...
- ▸If Tandem Diabetes Care continues to deliver earnings and revenue above analyst estimates in subsequent quarters Institutional investors may reassess growth and profitability assumptions for Tandem Diabetes Care, potentially increasing capital allocation to the diabetes device segment.
Market Exposure
StocksTandem Diabetes Care Inc. (TNDM)Increased Volatility
If investors react strongly to the earnings and revenue beat, TNDM shares could see increased volatility as market participants adjust positions and expectations.
Key Actors
Organizations
Source Coverage
FINANCE
4 articles
More coverage on this story
- More on Tandem Diabetes Care, Inc.
Signals
Single-block coverageLow source diversity
Related Events
▸Anterix earnings beat by $0.25, revenue topped estimatesArchived▸Jackson Financial Non-GAAP EPS of $6.61 beats by $0.75, revenue of $1.99B beats by $70MArchived▸GoodRx Holdings Reports Q4 Non-GAAP EPS $0.09, Revenue $195MArchived▸Gladstone Commercial earnings beat by $0.03, revenue topped estimatesArchived▸Sun quarterly profit beats Wall Street forecasts
Primary Sources (4)
FINANCEInvesting.com - NewsEuroDry earnings beat by $0.39, revenue topped estimatesFINANCESeeking Alpha - Market NewsRimini Street GAAP EPS of $0.39 beats by $0.35, revenue of $109.8M beats by $4.33MFINANCESeeking Alpha - Market NewsChemours Non-GAAP EPS of $0.05 beats by $0.03, revenue of $1.33B in-lineFINANCE